198. The Future of Transplant ID: Novel Diagnostics and Therapeutics
Saturday, October 6, 2018: 8:45 AM-10:00 AM
Room: S 214-216

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • evaluate new diagnostic tools and their applications in transplant infectious diseases
  • review and categorize approaches to immunosuppressive therapy, emphasizing the relevance of each from an infectious diseases perspective
  • discuss emerging transplant modalities and the implications for infectious diseases providers

Target Audience: Academicians, Clinicians, Fellows, Healthcare workers, Infectious diseases pediatricians, Infectious diseases physicians, Lab personnel, Medical students and residents, Members-in-training, Microbiologists, Nurses, Pharmacists

Tracks: Transplant ID, Trainee, Pediatric ID, Adult ID

Moderators:  Raymund R. Razonable, MD, FIDSA, Mayo Clinic and Maricar Malinis, MD, FACP, FIDSA, Yale School of Medicine

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE

ACPE Number: 0221-9999-18-262-L01-P


R. R. Razonable, None

M. Malinis, None

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.